Sioufi A, Pommier F, Dubois J P
Laboratoires Ciba-Geigy, Biopharmaceutical Research Centre, Rueil-Malmaison, France.
J Chromatogr. 1988 Jun 24;428(1):71-80. doi: 10.1016/s0378-4347(00)83891-8.
A method for the simultaneous determination of clomipramine and its N-desmethyl metabolite at concentrations down to ca. 2 nmol/l in human whole blood is described. After addition of a known amount of deuterium-labelled internal standards, compounds are extracted into n-heptane-isoamyl alcohol (99:1, v/v) at basic pH, back-extracted into an acidic aqueous solution and re-extracted at basic pH into n-heptane. N-Desmethylclomipramine and the internal standard are derivatized with pentafluoropropionic anhydride. The compounds are determined by capillary gas chromatography with mass-selective detection. The technique was applied to determine the human blood concentrations of clomipramine and its N-desmethyl metabolite after oral administration of Anafranil; mean blood concentrations are reported.
本文描述了一种可同时测定人全血中氯米帕明及其N-去甲基代谢物的方法,检测浓度低至约2 nmol/L。加入已知量的氘标记内标后,在碱性pH条件下将化合物萃取到正庚烷-异戊醇(99:1,v/v)中,再反萃取到酸性水溶液中,然后在碱性pH条件下重新萃取到正庚烷中。N-去甲基氯米帕明和内标用五氟丙酸酐进行衍生化。通过毛细管气相色谱-质谱选择性检测来测定这些化合物。该技术用于测定口服安拿芬尼后人体血液中氯米帕明及其N-去甲基代谢物的浓度,并报告了平均血药浓度。